Ponatinib in the treatment of patients with chronic myeloid leukemia and increased cardiovascular risk: A review of management strategies
Article in Hematology Transfusion and Cell Therapy (August 2024)
The most recent citing publications are shown below. View all 13 publications that cite this research output on Dimensions.
Computational biophysical characterization of the effect of gatekeeper mutations on the binding of ponatinib to the FGFR kinase
Article in Archives of Biochemistry and Biophysics (June 2024)
A New Algorithm Integrating Molecular Response, Toxicity, and Plasma Level Measures for Ponatinib Dose Choice in Patients Affected by Chronic Myeloid Leukemia
Article in Pharmaceutics (March 2024)